Bots, editor, reviewer, Administrators
13,951
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 4,885: | Line 4,885: | ||
"title" : "Intensive Insulin Therapy in Critically Ill Patients", | "title" : "Intensive Insulin Therapy in Critically Ill Patients", | ||
"pmid" : "11794168" | "pmid" : "11794168" | ||
}, | |||
{ | |||
"timestamp" : "2024-04-01T20:43:48Z", | |||
"briefDesignDescription" : "ARB vs. B-blocker in HTN with LVH", | |||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)08089-3/abstract", | |||
"pageid" : 2439, | |||
"pdfurl" : "http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(02)08089-3.pdf", | |||
"trainingLevel" : "Student", | |||
"citation" : "Dahlof B, <i>et al</i>. \"Cardiovascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE)\". <i>The Lancet</i>. 2002. 359:995-1003.", | |||
"subspecialties" : "Nephrology", | |||
"expansion" : "Cardiovvascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol", | |||
"statusUsableDate" : "2023-03-28", | |||
"briefResultsDescription" : "Losartan lowers stroke, MI, or CVD mortality vs. atenolol in HTN with LVH", | |||
"published" : "2002-03-23", | |||
"pageName" : "LIFE", | |||
"diseases" : "Hypertension;Cardiovascular Disease;Stroke", | |||
"abbreviation" : "LIFE", | |||
"title" : "Cardiovascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE)", | |||
"pmid" : "11937178" | |||
}, | }, | ||
{ | { | ||